Wednesday, May 29, 2024

Hokkaido scientists identify novel defence mechanism for SARS-CoV-2

A novel defensive response to SARS-CoV-2 involving the viral pattern recognition receptor RIG-I has been discovered by scientists from Hokkaido University, Medical Xpress reports. Upregulating expression of this protein could strengthen the immune response in COPD patients. A team led by professor Akinori Takaoka has shown that RIG-I, a biological molecule that detects RNA viruses, restrains SARS-CoV-2 replication in human lung cells. Their findings, which could help predict COVID-19 patient outcomes, were published in the journal Nature Immunology. More than 162 million people have been affected by COVID-19. About 40-45% of these individuals are asymptomatic; as for the rest, around 35%-40% experienced a mild form of the disease, while the remaining roughly 19% were affected by symptoms that were severe enough to warrant hospitalization or were fatal. The most severe outcomes are usually associated with comorbidities and risk factors such as chronic obstructive pulmonary disease (COPD).

BIG Media
BIG Media
Our focus is on facts, accurate data, and logical interpretation. Our only agenda is the truth.

BIG Wrap

U.S. Gaza pier knocked out of action by heavy seas

(BBC News) A temporary pier built by the US military to deliver aid to Gaza has been damaged by heavy seas and will take...

Civilian deaths in Rafah strike a tragic mishap, Netanyahu says

(BBC News) Israeli Prime Minister Benjamin Netanyahu says the strike that killed scores of displaced Palestinians in Rafah on Sunday was a "tragic mishap", amid...